Kingfisher Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Kingfisher Capital's AMGN Position: Q3 2019 in Review
Kingfisher Capital sold out of Amgen (AMGN) in Q3 2019, closing a stake of 10,334 shares — an estimated $1.9M sold.
Kingfisher Capital first reported a position in AMGN in Q3 2015 and held it in 16 quarters. The position peaked at $2.14M in Q3 2018. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.
- Kingfisher Capital reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
- Kingfisher Capital sold 10,334 Amgen shares in Q3 2019, an estimated $1.9M.
- Kingfisher Capital first reported a position in Amgen in Q3 2015 and held it in 16 quarters.
- Kingfisher Capital's Amgen position peaked at $2.14M in Q3 2018.
- 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.
Based on Kingfisher Capital's 13F filing for Q3 2019, filed 12 Nov 2019.